Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after
Giovanni Luca Frassineti, MD
Advertisement
Articles by Giovanni Luca Frassineti, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
The Gynecologic Oncology Data to Watch at ESMO 2026: De-Escalation and ADCs
2
Cancer Vaccine Combinations Improve 1-Year Survival in Second-Line NSCLC
3
Trispecific CAR T Cells Demonstrate Safety, Early Activity in B-Cell Lymphoma
4
The Usefulness of Indocyanine Green in Cytoreductive Ovarian Cancer Surgery
5